Clark Capital Management Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-318,851
Closed -$22M 463
2025
Q2
$22M Sell
318,851
-291
-0.1% -$19.8K 0.15% 146
2025
Q1
$22.2M Buy
319,142
+3,250
+1% +$268K 0.16% 142
2024
Q4
$27.2M Sell
315,892
-205,426
-39% -$22.2M 0.19% 135
2024
Q3
$62.1M Sell
521,318
-125,784
-19% -$16.8M 0.43% 74
2024
Q2
$92.4M Buy
647,102
+12,364
+2% +$1.64M 0.68% 34
2024
Q1
$81.5M Buy
634,738
+17,085
+3% +$2.03M 0.61% 39
2023
Q4
$63.9M Buy
617,653
+22,995
+4% +$2.27M 0.52% 46
2023
Q3
$54.1M Buy
594,658
+18,150
+3% +$1.6M 0.54% 48
2023
Q2
$46.6M Buy
576,508
+21,932
+4% +$1.79M 0.42% 63
2023
Q1
$44.1M Buy
554,576
+13,900
+3% +$986K 0.49% 61
2022
Q4
$36.6M Buy
540,676
+16,346
+3% +$958K 0.34% 76
2022
Q3
$26.1M Buy
524,330
+15,158
+3% +$812K 0.34% 90
2022
Q2
$28.4M Buy
509,172
+27,550
+6% +$1.53M 0.37% 75
2022
Q1
$26.7M Buy
481,622
+475,124
+7,312% +$24.4M 0.3% 116
2021
Q4
$364K Sell
6,498
-577,692
-99% -$31.3M ﹤0.01% 301
2021
Q3
$28M Buy
584,190
+24,622
+4% +$1.19M 0.38% 103
2021
Q2
$23.4M Buy
+559,568
New +$21.7M 0.33% 134
2017
Q4
Sell
-313,136
Closed -$7.54M 309
2017
Q3
$7.54M Sell
313,136
-42,034
-12% -$950K 0.25% 108
2017
Q2
$7.62M Buy
+355,170
New +$7.17M 0.3% 100
2016
Q2
Sell
-11,310
Closed -$306K 336
2016
Q1
$306K Sell
11,310
-998
-8% -$26.7K 0.02% 269
2015
Q4
$357K Sell
12,308
-154
-1% -$4.26K 0.03% 244
2015
Q3
$338K Buy
12,462
+12
+0.1% +$340 0.03% 245
2015
Q2
$341K Buy
12,450
+86
+0.7% +$2.42K 0.03% 254
2015
Q1
$330K Sell
12,364
-1,624
-12% -$37.4K 0.03% 259
2014
Q4
$296K Sell
13,988
-212
-1% -$4.74K 0.03% 251
2014
Q3
$338K Buy
14,200
+756
+6% +$17.4K 0.03% 230
2014
Q2
$310K Sell
13,444
-530
-4% -$11.7K 0.03% 251
2014
Q1
$319K Sell
13,974
-4,956
-26% -$106K 0.03% 250
2013
Q4
$350K Sell
18,930
-810
-4% -$14.1K 0.03% 238
2013
Q3
$334K Sell
19,740
-1,440
-7% -$24.2K 0.03% 253
2013
Q2
$328K Buy
+21,180
New +$353K 0.03% 246

Other funds holding NVO